PB2501: INSIGHT-1: A PHASE I FIRST-IN-HUMAN TCR TRIAL OF GENETICALLY MODIFIED T-CELLS TARGETING TDT IN CHILDREN AND ADULTS WITH T- AND B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA (TRIAL-IN-PROGRESS)
Jochen Buechner,
Even Holth Rustad,
Saskia Meyer,
Thea Gjerdingen,
Eirini Giannakopoulou,
Muhammad Ali,
Ingerid Weum Abrahamsen,
Anna Pasetto,
Ying Yuan,
Johanna Olweus
Affiliations
Jochen Buechner
1 Oslo University Hospital, Department of Pediatric Hematology and Oncology, Oslo, Norway
Even Holth Rustad
2 University of Oslo, Institute of Clinical Medicine, Oslo, Norway
Saskia Meyer
2 University of Oslo, Institute of Clinical Medicine, Oslo, Norway
Thea Gjerdingen
2 University of Oslo, Institute of Clinical Medicine, Oslo, Norway
Eirini Giannakopoulou
2 University of Oslo, Institute of Clinical Medicine, Oslo, Norway
Muhammad Ali
2 University of Oslo, Institute of Clinical Medicine, Oslo, Norway
Ingerid Weum Abrahamsen
3 Oslo University Hospital, Department of Haematology, Oslo, Norway
Anna Pasetto
2 University of Oslo, Institute of Clinical Medicine, Oslo, Norway
Ying Yuan
5 University of Texas MD Anderson Cancer Center, Department of Biostatistics, Houston, United States
Johanna Olweus
2 University of Oslo, Institute of Clinical Medicine, Oslo, Norway
